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Introduction
▼
Ultra-marathon running events have become 
increasingly popular in the last few years, nota-
bly in the US, Europe, Japan, Korea and South 
Africa. Ultra-marathon is defined as a race involv-
ing a distance longer than the official marathon 
(42.2 km). Ultra-marathon competitions are gen-
erally performed on varied off-road terrains, 
completed over multiple days (multi-stage ultra-
marathons), or comprise races that cover a speci-
fied distance during a single stage and are 
typically performed in extreme environmental 
conditions [8, 34]. Ultra-marathon maybe a refer-
ence model for the study of physiological 
responses to extreme load and stress [35]. 
Because of prolonged physical exertion, ultra-
endurance running is associated with significant 
systemic inflammation [24, 42]. Hemolysis 
[10, 38] and leukocytosis [17] are common fea-
tures of prolonged strenuous exercise. Hemato-
logical changes may increase the susceptibility to 
illness and infection in the athlete population, 
consequently potentially interfering with perfor-
mance and health [5]. On the other hand, longi-
tudinal monitoring of hematological parameters 
within sports and exercise is accepted as a means 
to establish the practice use of illicit blood dop-
ing [2, 39, 44, 46]. Nevertheless, information on 
the hematological changes that occurs during 
consecutive days of ultra-endurance running is 
accepted after revision  
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Abstract
▼
This study examined the changes in resting 
hematological variables in ultra-endurance run-
ners throughout a multi-stage ultra-marathon 
competition, and compared athletes that com-
pleted all stages with those that failed to com-
plete at least one stage within the cut-off time of 
competition. 19 ultra-endurance runners com-
peting in a 230 km multi-stage ultra-marathon, 
conducted over 5 consecutive days in hot ambi-
ent conditions (32–40 °C Tmax), volunteered to 
participate in the study. Each day, whole blood 
samples were collected prior to stage commence-
ment and analyzed for full cell counts by Coulter 
counter. Linear increases were observed for leu-
kocytes, monocytes and lymphocytes; with 
increases until Stage 3 and a decrease thereafter. 
Granulocytes showed a cubic growth exponent, 
indicating decrements to baseline after the sig-
nificant increments until Stage 3. Hemoglobin 
and hematocrit showed linear decrements 
throughout the multi-stage ultra-marathon. No 
changes in erythrocytes and platelets were 
observed throughout the multi-stage ultra-ma-
rathon. Granulocytes, erythrocytes, hemoglobin 
and hematocrit changes along the multi-stage 
ultra-marathon differed in runners that com-
pleted all stages compared to those who failed to 
complete at least one stage within the cut-off 
time. Multi-stage ultra-marathon in the heat has 
a large impact on hematological responses of 
ultra-endurance runners associated with altered 
performance.
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limited [37]. As such, the available data on prolonged endurance 
running mainly deals with marathons [25, 40].
The multi-stage ultra-marathon (MSUM) design is an interesting 
model of human behavior, since ultra-endurance runners need 
to perform extreme efforts on consecutive occasions interposed 
with potentially limited recovery periods. Moreover, MSUM 
competition is commonly conducted in regions of the world 
exposed to environmental extremes (e. g., hot (> 30 °C) ambient 
conditions) [8]. Despite the other factors in a range of sporting 
events, no threat to the health and performance of the athlete is 
greater than that posed by prolonged hard exercise in a hot and 
humid environment [33]. Danger occurs if the thermoregulatory 
system is inadequate, as hyperthermia can impair the physiolog-
ical capacity for exercise and potentially cause heat injury and 
death [7]. Such heat extremes have the potential to exert hema-
tological changes associated with heat stress and heat 
acclimatization [8, 48]. Heat acclimatization, pre-exercise cooling 
and fluid ingestion are strategies supposed to attenuate the rise 
in core temperature, thus enhancing exercise performance [20].
The aim of this study was to examine the changes in hemato-
logical responses in ultra-endurance runners during a MSUM 
competition conducted in hot ambient conditions comparing 
the patterns of hematological indicator responses between ath-
letes that completed all the stages within the cut-off times and 
those that failed to complete at least one stage within the cut-off 
time but were allowed to complete the entire ultra-marathon 
event.
Materials and Methods
▼
Participants
Before the start of this study, ethical approval was obtained from 
the Coventry University Ethics Committee that conforms to the 
2008 Helsinki declaration for human research ethics. In addition, 
the study protocol complies with the ethical standards of the 
International Journal of Sports Medicine [21]. Out of the 69 
ultra-endurance runners entering the MSUM, n = 19 volunteered 
to participate in the study [mean ± SD (male n = 13, female n = 6): 
age 43 ± 8 y, stature 172 cm ± 8 cm, body mass 71.2 ± 9.3 kg, body 
fat mass 16 ± 4 %]. All participant reported no illness and/or 
infection in the 12 weeks leading up to the MSUM. For research 
proposes, 2 groups were considered. A group of 14 runners com-
pleted the 230 km of the MSUM within the time frame, and a 
group of 5 slower runners, who failed to complete at least one 
stage before the cut-off time but were nevertheless considered 
in the overall classification and allowed to complete the compe-
tition.
Experimental design
The study was conducted during the 2011 Al Andalus Ultimate 
Trail (www.alandalus-ut.com), during the second week of July, 
in the region of Loja, Spain. All the participants arrived at the 
MSUM location  ≤ 48 h prior to the start of Stage 1. Only 28 % of 
participants resided in countries with hot ambient conditions 
similar to those of the race location (≥ 30 °C) at the time of com-
petition; while the remaining 72 % of participants resided in 
countries that presented cold or thermoneutral environmental 
conditions (≤ 20 °C) [9]. The MSUM was conducted over 5 stages 
(5 days) totaling a distance of 230 km (Stage 1: 37 km, Stage 2: 
48 km, Stage 3: 38 km, Stage 4: 69 km, and Stage 5: 38 km, 
respectively) in 28 h17 min ± 4 h15 min (average speed: 
8.1 ± 1.3 km · h − 1), which was performed on a variety of terrains; 
predominantly off-road trails and paths, but also included steep 
and narrow mountain passes, and occasional roads [15]
Running intensity averaged 8.0, 8.1, 7.1, 7.0, and 7.5 metabolic 
equivalents (METs) (SenseWear 7.0, BodyMedia Inc., Pittsburgh, 
PA, USA) from Stages 1 to 5, respectively. Sleeping arrangements 
along the course included a combination of outdoor tent and vil-
lage sports hall accommodation [sleep duration (mean ± SD) 
8 h10 min ± 0 h43 min, 7 h50 min ± 0 h36 min, 8 h32 min ± 0 h51 min, 
8 h18 min ± 1 h05 min, during Stages 1 to 5, respectively].
The daily maximum temperature ranged between 32 and 40 
over the 5 days of competition, with maximum relative humid-
ity ranging between 32 and 40 % (Garmin International, Olathe, 
Kansas, US). The current MSUM required participants to be semi 
self-sufficient, i. e., participants planned and provided their own 
foods and fluids (except plain water) along the 5 days of compe-
tition. Participants’ equipment and sustenance was transported 
to each stage section by the race organization. Only plain water 
was provided by the race organizers ad libitum during the rest 
phase throughout competition. Additionally, aid stations along 
the course were situated approximately 10 km apart, and only 
provided plain water, fruit (oranges and watermelon), and elec-
trolyte supplementation (Elete electrolyte add-in, Mineral 
Resources International, South Ogden, Utah, US). Participants 
were advised to adhere to their programmed routine dietary 
practices throughout the MSUM competition.
Each day, for 5 consecutive days, running stages commenced at 
either 08:00 or 09:00 h. Within the hour prior to the start of each 
running stage, pre-stage blood samples were collected. Partici-
pants were then required to sit for 10 min before blood sampling. 
Blood samples were collected by venipuncture without venosta-
sis from an antecubital vein using a 21 G butterfly syringe into 
one K3EDTA vacutainer tube. The same procedure was con-
ducted at the end of each stage for further analysis (data not 
shown).
Blood analysis
Blood samples were immediately centrifuged and plasma ali-
quoted into Eppendorfs and stored frozen initially at  − 20 °C dur-
ing the ultra-marathon competition, prior to transferring 
to  − 80 °C storage after completion for other analysis related to 
plasma content [9]. Whole blood hemoglobin concentration and 
hematocrit value of K3EDTA whole blood samples (100 µl) were 
determined immediately after sample collection. Hemoglobin 
concentration and hematocrit value were used to estimate 
changes in PV relative to pre-Stage 1, established as baseline. All 
the blood cell counts (leukocyte, lymphocyte, monocyte, granu-
locytes, erythrocytes) were corrected for changes in PV [12]. Cell 
counts were determined using a cell counter (Coulter ACT Diff, 
Beckham Coulter, USA). Leukocyte blood cell counts were ana-
lyzed for possible changes in lymphocyte and granulocyte levels 
indicative of immune function impairment while the red cells 
parameters were analyzed for indications of decreased oxygen 
availability.
Statistical analysis
Descriptive statistics for all dependent variables at all measure-
ment points are presented as mean ± standard deviation. Tradi-
tional analysis of variance for repeated measures may be 
inappropriate for non-linear data [18, 26, 43]. We thus consid-
ered alternative hierarchical/multi-level modeling, allowing for 
polynomial structures, to describe the changes in hematological 
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indicator responses as a consequence of participating in the 
MSUM, as used previously to examine athletes’ repeated meas-
urements [45]. Each athlete’s successive measurements over 
time were analyzed, considering both the possibility of linear 
(linear term) and non-linear (squared linear term, cubic linear 
term) changes and random error. At Level 2, the individual 
growth parameters from Level 1 were treated as outcomes that 
allowed examination of whether athletes differed in their initial 
status or rates of change, and if so, what explained that variation. 
The initial Level 2 model specifications were unconditional 
growth models that included no substantive time-invariant pre-
dictors and simply allowed each Level 1 individual growth 
parameter to differ randomly in terms of its population (between 
individuals). Individual changes were expressed as percent 
changes via logarithmic transformation of the dependent varia-
bles. Also the dependent variables were centered on the mean of 
baseline outcome (measurements at stage 1).
We also examined whether athletes who were not able to com-
plete a stage within the cut-off time (n = 5) had different inter-
cepts (initial values), rate of change, and acceleration in the 
outcomes compared to the athletes that completed all stages 
(n = 14). This was incorporated in the models as a dummy varia-
ble to categorize the athletes’ performance (binary variable – 
athletes that completed all stages coded: 0; and athletes not able 
to complete a stage within the control time coded: 1) and 
included at level 2. To explore differences in the rate of changes 
across the ultra-marathon we included in the models interac-
tion terms between the growth terms and athletes performance 
category. Significance was set at P < 0.05. In addition to statistical 
inference based on a null hypothesis test, qualitative probabilis-
tic inference about the effects on the hematological outcomes 
across the ultra-marathon were included [22]. The between-
subject standard deviation for each dependent variable at the 
baseline was used to convert the absolute change in responses 
into standardized (Cohen) changes in the mean. Threshold val-
ues for interpreting magnitudes of standardized effects were 
0.20, 0.60, 1.20, and 2.00 for small, moderate, large and very 
large, respectively [22].
Results
▼
Responses of hematological indicators across the MSUM at the 
different time points are summarized in  ●▶  Table 1. The mean 
percent changes and error of measurement (intra-individual 
coefficients of variation) in hematological indicators over the 
MSUM are shown in  ●▶  Fig. 1–3. Differences in the mean percent 
changes between athletes grouped by ultra-marathon comple-
tion are shown in  ●▶  Fig. 4. The amplitude of PV variation through-
out the MSUM ranged from 2.43 ± 10.81 % (Stage 1) to 
17.84 ± 14.33 % (Stage 5).
 ●▶  Table 2 shows the multi-level regression analysis for leuko-
cytes, lymphocytes, monocytes, and granulocytes changes with 
the MSUM. Linear percent changes were observed for mono-
cytes (P < 0.01). On average, changes from baseline along the 
MSUM presented a non-linear pattern for leukocytes, lympho-
cytes, and granulocytes. Leukocytes (P < 0.01) and lymphocytes 
(P < 0.05) showed an increase until Stage 3 and decrease thereaf-
ter (P < 0.01 for leukocytes; P < 0.05 for lymphocytes). As for 
granulocytes, the cubic growth exponent (P < 0.05) indicates 
that the decrements in changes to baseline after Stage 3 tend to 
stabilize decreases ( ●▶  Fig. 1).
The results of multi-level regression analysis for erythrocytes, 
hemoglobin, hematocrit and platelet changes with the MSUM 
Table 1 Mean (SD) in resting pre-stage hematological indicators throughout a multi-stage ultra-marathon (n = 19).
Stage 1 Stage 2 Stage 3 Stage 4 Stage 5
Leukocytes (× 109/L) 5.8 (0.9) 7.1 (1.7) 7.3 (1.7) 7.0 (1.6) 6.9 (1.5)
Lymphocytes (× 109/L) 2.1 (0.3) 2.1 (0.4) 2.3 (0.4) 2.4 (0.5) 1.9 (0.4)
Monocytes (× 109/L) 0.4 (0.1) 0.4 (0.1) 0.4 (0.1) 0.4 (0.2) 0.6 (0.2)
Granulocytes (× 109/L) 3.3 (0.9) 4.6 (1.6) 4.7 (1.6) 4.2 (1.2) 4.5 (1.5)
Erythrocytes (× 109/L) 4.9 (0.4) 4.9 (0.5) 5.1 (0.8) 5.4 (0.7) 5.3 (0.7)
Hemoglobin (g/dl) 16.1 (1.2) 15.6 (1.3) 14.9 (1.9) 15.5 (1.1) 15.0 (1.4)
Hematocrit (g/dl) 45.2 (3.2) 43.7 (3.5) 41.8 (5.3) 43.1 (3.1) 41.5 (4.0)
Platelet (× 109/L) 224.8 (55.4) 237.8 (55.4) 251.3 (76.9) 247.2 (67.0) 261.1 (67.2)
Mean corpuscular volume (fL) 91.5 (2.2) 91.0 (2.3) 91.2 (2.4) 91.2 (2.4) 91.2 (2.1)
Mean corpuscular hemoglobin (pg) 32.7 (0.9) 32.5 (0.9) 32.6 (5.3) 32.9 (0.9) 33.0 (0.9)
Mean concentration of corpuscular hemoglobin (g/dL) 35.7 (0.5) 35.7 (0.4) 35.8 (0.4) 36.1 (0.4) 36.2 (0.4)
Mean of platelet volume (fL) 8.5 (0.8) 9.0 (0.9) 9.0 (0.9) 9.0 (0.9) 8.8 (0.9)
Fig. 1 Changes from baseline, in percentage of leukocytes levels and subset counts in the peripheral blood at the beginning of each stage of a multi-stage 
ultra-marathon (Panel a leukocytes; Panel b lymphocytes; Panel c monocytes; Panel d granulocytes). The shaded area indicates trivial changes, the dash 
line indicates the lower limit for moderate changes, and the dotted line indicates the lower limit for large changes ( < 0.20,  > 0.60, and  > 1.20 of baseline 
between-subject standard deviation (SD) averaged). Bars are the standard error of changes from baseline.
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Table 2 Multi-level regression analysis of log transformed leukocytes, lymphocytes, monocytes and granulocytes changes induced by a multi-stage ultra-
marathon competition.
Leukocytes Lymphocytes Monocytes Granulocytes
Fixed Explanatory Variables
Exponent value (standard error)
Intercept 0.013 (0.038)  − 0.023 (0.036) 0.006 (0.078) 0.050 (0.050)
Linear growth 0.178 (0.048)* * 0.092 (0.045) * 0.109 (0.033)* * 0.530 (0.163)* *
Quadratic growth  − 0.037 (0.012)* *  − 0.025 (0.012) * –  − 0.259 (0.106) *
Cubic growth – – – 0.036 (0.018) *
Performance group (reference: athletes that completed the race) – – –  − 0.192 (0.075)* *
Variance-Covariance Matrix of Random Variables
Level 1 (within individuals)
Repeated measures variance 0.038 (0.008)* * 0.027 (0.005)* * 0.187 (0.029)* * 0.073 (0.013)* *
Level 2 (between individuals)
Variance 0.010 (0.004) 0.000 (0.000) 0.000 (0.000) 0.000 (0.000)
 − 2 Restricted Log Likelihood  − 33.313  − 44.567 98.594 29.128
Akaike’s Information Criterion  − 23.313  − 34.567 106.594 43.128
 * * P ≤ 0.01; * P ≤ 0.05
Fig. 2 Changes from baseline in percentage of the red series in the peripheral blood at the beginning of each stage of a multi-stage ultra-marathon (Panel 
a erythrocytes; Panel b hemoglobin; Panel c hematocrit; Panel d platelets). The shaded area indicates trivial changes, the dash line indicates the lower limit 
for moderate changes, and the dotted line indicates the lower limit for large changes ( < 0.20,  > 0.60, and  > 1.20 of baseline between-subject standard 
deviation (SD) averaged). Bars are the standard error of changes from baseline.
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Fig. 4 Changes from baseline between ultra-endurance runners that have completed the entire multi-stage ultra-marathon competition (represented with 
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are presented in  ●▶  Table 3. No changes across the MSUM were 
observed for erythrocytes and platelets (P > 0.05). However, the 
magnitude of the standardized effects were moderate suggest-
ing that at least a small effect of running an ultra-marathon need 
to be considered in the variables. Hemoglobin (P < 0.05) and 
hematocrit (P < 0.01) had linear decrements from Stage 1 at a 
rate of approximately 15 and 19 % respectively. Moreover, the 
magnitude of the standardized effects was at least moderate.
The results of multi-level regression analysis of log transformed 
mean corpuscular volume (MCV), mean corpuscular hemo-
globin (MCH), mean concentration of corpuscular hemoglobin 
(MCCH) and mean platelet volume (MPV) changes are shown 
in  ●▶  Table 4. No changes across the MSUM were observed for 
MCV and MCH (P > 0.05). However, the magnitude of the stand-
ardized effects were moderate at Stages 4 and 5 suggesting that 
at least a small effect needs to be considered in the variable 
within the final stages of the ultra-marathon. MCCH presented 
linear increments from Stage 1 at a rate of 4 % (P < 0.01). MPV 
changes with the MSUM had a non-linear pattern (P < 0.01) indi-
cating a linear increase and a final levelling-off in the percent 
changes.
The ultra-endurance runners that were able to complete all the 
stages of the ultra-marathon had higher values of erythrocytes, 
hemoglobin and hematocrit (approximately 9 %, P < 0.001) com-
pared to the ultra-endurance runners that failed to complete all 
the stages within the cut-off time. Differences were also 
observed for granulocytes (P < 0.01). No differences in the rate of 
changes were found between ultra-endurance runners when 
exploring in the model the interaction term between growth 
exponents and athletes performance category (P > 0.05).
No differences in changes in mean to baseline for MCV, MCH, 
MCCH and MPV changes were found between the ultra-endur-
ance runners grouped by performance category.
Discussion
▼
The present study examined the changes in resting hematologi-
cal responses in ultra-endurance runners throughout a MSUM. 
The main findings were a decrease in hematocrit and hemo-
globin concentrations throughout the race, and a difference in 
these parameters between the athletes that completed all the 
stages of the race and those who failed to complete at least one 
of the stages. As expected, large within-athlete variability in 
hematological indicator responses during the MSUM was 
observed; this is probably due to variability in training status 
and acclimatization since hydration status was maintained dur-
ing the run (9). Leukocytes had a non-linear increase during the 
ultra-marathon until Stage 3 and decrease thereafter. The leuko-
cytes subset counts variability during the MSUM showed that 
monocytes had a steady increase, granulocytes had an increase 
and tended to plateau after Stage 3, and lymphocytes tended to 
reach baseline values at the end of the ultra-marathon competi-
tion after an initial substantial increase (peaking at Stage 3). The 
Table 3 Multi-level regression analysis of log transformed erythrocytes, hemoglobin, hematocrit and platelet changes induced by a multi-stage ultra-mara-
thon competition.
Erythrocytes Hemoglobin Hematocrit Platelet
Fixed Explanatory Variables
Exponent value (standard error)
Intercept  − 0.016 (0.018) 0.009 (0.016) 0.010 (0.015) 0.004 (0.034)
Linear growth  − 0.016 (0.011)  − 0.015 (0.007) *  − 0.019 (0.007) ** 0.043 (0.035)
Performance group (reference: athletes that completed the race)  − 0.087 (0.037) * *  − 0.095 (0.027) * *  − 0.090 (0.027) * –
Variance-Covariance Matrix of Random Variables
Level 1 (within individuals)
Repeated measures variance 0.006 (0.001) * * 0.006 (0.001) * * 0.006 (0.001) * 0.008 (0.001) * *
Level 2 (between individuals)
Variance 0.001 (0.001) * * 0.000 (0.000) * 0.000 (0.000) * 0.022 (0.006) * *
 − 2 Restricted Log Likelihood  − 151.822  − 194.331  − 195.679  − 57.305
Akaike’s Information Criterion  − 141. 822  − 184.331  − 185.679  − 49.305
 * * P ≤ 0.01; * P ≤ 0.05
Table 4 Multi-level regression analysis of log transformed mean corpuscular volume, mean corpuscular hemoglobin, mean concentration of corpuscular 
hemoglobin and mean of platelet volume changes induced by a multi-stage ultra-marathon competition.
Mean corpuscu-
lar volume
Mean corpuscular 
hemoglobin
Mean concentration of 
corpuscular hemoglobin
Mean of platelet 
volume
Fixed Explanatory Variables
Exponent value (standard error)
Intercept  − 0.001 (0.000)  − 0.004 (0.04)  − 0.001 (0.001) 0.006 (0.014)
Linear growth  − 0.000 (0.004) 0.003 (0.004) 0.004 (0.001) * * 0.048 (0.015) * *
Quadratic growth – – –  − 0.011 (0.001) * *
Variance-Covariance Matrix of Random Variables
Level 1 (within individuals)
Repeated measures variance 0.000 (0.000) * * 0.000 (0.000) * * 0.000 (0.000) * * 0.001 (0.000) * *
Level 2 (between individuals)
Variance 0.000 (0.000) * * 0.000 (0.000) * * 0.000 (0.000) * * 0.003 (0.001) * *
 − 2 Restricted Log Likelihood  − 547.889  − 505.625  − 579.178  − 281.525
Akaike's Information Criterion  − 539.889  − 497.625  − 571.178  − 271.525
* * P ≤ 0.01;  *P ≤ 0.05
D
ow
nl
oa
de
d 
by
: D
ot
. L
ib
 In
fo
rm
at
io
n.
 C
op
yr
ig
ht
ed
 m
at
er
ia
l.
109Physiology & Biochemistry
Rama LM et al. Changes of Hematological Markers … Int J Sports Med 2016; 37: 104–111
erythrocytes changes during the MSUM were linear and posi-
tive, showing at least small effect sizes after stage 3.
Hemoglobin and hematocrit showed a substantial linear 
decrease (effect sizes above 0.2 after stage 2); whereas platelets 
had a substantial increase throughout the MSUM (effect sizes 
above 0.2 after stage 3). Mean corpuscular volume and mean 
corpuscular hemoglobin values did not change throughout the 
ultra-marathon. Significant increases in mean of platelet volume 
and mean concentration of corpuscular hemoglobin were 
observed, peaking at Stage 4 and Stage 5, respectively. Notewor-
thy, ultra-runners that completed all stages had higher magni-
tude of change for granulocytes, erythrocytes, hemoglobin and 
hematocrit compared to those who fail to complete at least one 
stage within the cut-off time.
White cell parameters
The present results showed that a transient leukocytosis, lym-
phopenia and monocytosis is induced by the participation in a 
competitive MSUM in the heat, consistent with an inflammatory 
reaction to tissue injury [25]. Our data is consistent with limited 
observations in a marathon [25], a continuous one-stage ultra-
marathon (308 km) [42] and an extreme multi-stage ultra-mar-
athon (about 1 600 km) [14], all in temperate condition. The 
acute variation of leukocytes following a half-marathon run 
(21.1 km) in 17 adult runners showed an increase after the run 
and peak values around 3 h after cessation, but returned to base-
line at 24 h [30]. The increases in the leukocytes counts in the 
present study suggest that the recovery period between the end 
of a stage and the beginning of the next stage was not sufficient 
for restoring baseline values. However, changes in leukocyte 
counts should be carefully interpreted since they may only 
reflect leukocyte redistribution from circulation into tissues, 
possibly to enhance immune surveillance or due to tissue 
trauma/injury associated with prolonged strenuous exercise 
[41], and not necessarily a negative immune perturbation [28].
Monocytes are powerful innate defense cells and produce sev-
eral pro-inflammatory proteins. Exercise induces monocytosis, 
as well as functional changes in these cells such as phagocytic 
activity and cytokine production [5]. The shifting of monocytes 
from the marginated to the circulating pool induced by acute 
exercise may be explained by a hemodynamic and/or cortisol or 
catecholamine-induced release from the vascular endothelium 
[27, 28]. It has been observed that high-intensity exercise exerts 
lymphopenia, a decrease in the number of circulating lympho-
cytes [32]. Interestingly, in the present study, despite exercise 
being low intensity for a prolonged period of time, lymphopenia 
was observed following Stage 4, which was the longest stage of 
the ultra-marathon race. Lymphocyte death induced by exercise 
is dependent of intensity and probably duration of the exercise 
involving different mechanisms in athletes [29]. It was showed 
that exposure to a marathon increased the percentage of apop-
totic and necrotic lymphocytes, and decreased the percentage of 
viable lymphocytes [40]. On the other hand, apoptosis sensitiv-
ity seems to be related to training status. Lower percentages of 
apoptotic cells in highly trained athletes have been shown when 
compared with trained athletes of a lesser fitness level [36]. The 
maintenance of lymphopenia during the MUSM in the present 
study suggests impairment in acquired immunity.
Endurance running is commonly associated with significant sys-
temic inflammation [3]. Thus, the transient leukocytosis, mono-
cytosis, lymphopenia, and increases in granulocytes (principally 
because of neutrophilia) could represent the response to an 
inflammatory process induced by exertional-stress [42]. This 
transient perturbation in cell numbers and functions usually 
return to pre-exercise values within 24 h [23]. If recovery 
between exercise sessions is insufficient, it is possible that the 
combined effects of small changes in several aspects of host 
defense may compromise resistance to minor illnesses, such as 
respiratory infections [47].
Red cell parameters
The increases in erythrocytes in the present study are consisted 
with comparable data observed in 9 athletes after 4 stages in a 
multi-stage ultra-endurance run [14]. The significant decreases 
of hemoglobin and hematocrit responses to ultra-endurance 
running in the present study are in line with a previous report 
[14], probably reflecting the impact of physical exertion of the 
ultra-marathon. The substantial increases in platelets observed 
as a consequence of ultra-endurance running in the present 
study are consistent with previous observations [14, 38]. This is 
expected because the inflammatory reaction usually evokes 
increases in platelet counts, similar to those seen in leucocytes. 
The rise in number of circulating platelets is probably due to the 
release of mature platelets from the splenic pool. This probably 
does not reflect any pathological condition for athletes, even 
during extreme performances [4].
Hemodilution has been shown to occur in already well-trained 
runners [14]. Adaptive changes, i. e., acute plasma hypervolemic 
response observed, possibly due to heat acclimation [8], poten-
tially contributed towards optimizing thermoregulatory 
response and hydration status during exercise-heat stress [6]. 
Changes in hemoglobin and hematocrit (while related to plasma 
volume change) indicate the presence of anemia. However, in 
this case, it may be considered “pseudoanemia” that reflects an 
acute phase response common to strenuous endurance exercise 
of long duration. Athletes can adapt to these changes, and they 
are not deleterious to the athletes [14]; however, the possibility 
of both intravascular hemolysis from mechanical trauma, 
osmotic and oxidative damage to erythrocytes could also be con-
sidered [14]. Preparing the body to cope with exercising in hot 
ambient conditions by inducing favorable change in plasma vol-
ume appears to be a fundamental strategy ultra-endurance run-
ners should adopt to optimize performance and avoid unwanted 
heat-related illnesses [8], especially when a large majority of 
ultra-endurance runners come from countries with thermoneu-
tral to cold ambient conditions.
The magnitude of responses in erythrocytes, hemoglobin and 
hematocrit during the multi-stage race was different between 
ultra-endurance runners that completed all stages and those 
who failed to complete at least one stage within the cut-off time. 
The ultra-endurance runners that completed the whole race had 
significantly higher values at the beginning of the ultra-mara-
thon (i. e., following Stage 1) and maintained higher values 
throughout the race. The main function of red blood cells in 
exercise is the transport of oxygen, which bound to hemoglobin, 
circulates by cardiovascular function to the active muscle. 
Hemoglobin also contributes to the blood buffering capacity. 
Athletes that show a high oxygen transport capacity and buffer-
ing capacity have an advantage for aerobic athletic performance 
[31], as shown by our results. These results suggest that theo-
retically the availability of oxygen transport during exercise may 
be a limiting factor with regard to optimizing performance dur-
ing MSUM, ultimately limiting performance on consecutive days 
of competition.
D
ow
nl
oa
de
d 
by
: D
ot
. L
ib
 In
fo
rm
at
io
n.
 C
op
yr
ig
ht
ed
 m
at
er
ia
l.
110 Physiology & Biochemistry
Rama LM et al. Changes of Hematological Markers … Int J Sports Med 2016; 37: 104–111
Hematological responses are influenced by nutritional and 
hydration status, it is therefore plausible that sufficient food and 
fluid intake throughout competition may have attenuated any 
further disturbances in these hematological parameters and in 
immune status [16]. Heat stress can also significantly add to the 
challenges imposed on hematological responses, including links 
with thermoregulation human thermoregulatory system [20]. 
Exertional-heat stress can lead to serious performance decre-
ments and an increased risk of developing heat illness [1]. Ultra-
endurance runners demonstrating hematological changes 
favorable to heat acclimation would evoke better thermoregula-
tion; thus heat exchange between body and environment is sub-
stantially ameliorated, and the dangers associated with exercise 
in the heat are reduced [48].
Corpuscular indices
Hemorheology describes the flow characteristics of the blood 
and is generally applied as a diagnostic tool to revel diseases. The 
relationship between physical inactivity and cardiovascular dis-
ease was the precursor in the interest of exercise sciences in 
hemorheology [13]. Recent data in endurance-trained athletes is 
available for MCV, MCH, MCCH and MPV [6, 11, 25, 49, 51]. Addi-
tionally, diagnosis of the type of anemia may be assisted by relat-
ing the measurements of red blood cell count, hematocrit and 
hemoglobin to calculate the MCV and MCCH. Furthermore, a 
progressive and significant increase in MCH and MCCH probably 
indicate a loss in red cell water [11]. The exercise-induced hemo-
concentration is a result of fluid transfer from the blood to the 
interstitial spaces [13]. Elevated MCCH values probably indicate 
hemoconcentration and lower MCCH values indicate a greater 
flexibility in red cells [6]. Lower MCCH may be advantageous in 
facilitating blood flow and oxygen supply to the working muscle. 
In the present study, the MCCH had a substantial increase 
throughout the MSUM, peaking at Stage 5. This could be a com-
pensatory response, improving the oxygen delivery to the mus-
cles, due to the reduction in erythrocytes counts and hemoglobin 
concentrations seen throughout the MSUM. MPV is an indicator 
of platelet activation, generally used in clinical contexts (e. g., 
thrombotic risk in prehypertensive patients) [50]. The direct 
mechanical stress on circulating platelets may contribute for this 
activation [19], and could be explained by the increases in MPV 
in the present study.
Extreme exercise-heat stress was likely a contributing factor to 
the transient changes observed, regardless of exercise-induced 
adaptations. Results suggest that immune status was generally 
maintained, although assessment of other indicators of red cell 
production (i. e., reticulocyte variables) could have provided a 
more comprehensive overview [14]. Looking at the differences 
observed between athletes that completed the MSUM and those 
that failed to complete the entire race due to cut-off times, a 
lower performance was observed but not exposure of the run-
ners to any clinical risk was detected.
Conclusions
▼
In summary, the present study shows evidence of an inflamma-
tory reaction to tissue injury during a multi-stage ultra-mara-
thon competition conducted in hot ambient conditions and a 
transient lymphopenia in the latter stages of the race. Moreover, 
distinct patterns of change, in particular, the magnitude of 
change in red cells parameters and granulocytes were observed 
in ultra-endurance runners that completed all the stages of the 
run within the cut-off time and those who failed to complete at 
least one stage before the cut-off time. Having higher hemo-
globin levels and hematocrit seemed to confer a performance 
advantage in hot ambient conditions. As a result, multi-stage 
ultra-marathon competitions in the heat have a major impact on 
the hematological responses of ultra-endurance runners, and 
appear to influence overall performance. Monitoring of the ath-
letes’ hematological indicators in ultra-marathon competitions, 
particularly in hot ambient conditions, would be important for 
identifying the occurrence of pathological values at the begin-
ning or during a competition.
Acknowledgements
▼
Firstly, the authors would like to thank all the ultra-endurance 
runners that volunteered to participate in this study. The authors 
acknowledge the Al Andalus Ultimate Trail (www.alandalus-ut.
com) race directors Paul Bateson and Barbara Price; and Team 
Axarsport SL: Michelle Cutler and Eric Maroldo, for assisting and 
supporting various aspects of this study. The authors also 
acknowledge Volker Scheer, Encarna Valero-Burgos, Nina God-
son, Sue Cresswell, and Tim Morse for phlebotomy during the 
research design implementation; Emily Freeth, Edel Barrett, Jes-
sica Waterman, Slawomir Marczak, Samantha Gill, and Joanne 
Hankey for their support during the process of sample and data 
collection. The study was partly funded by Coventry University 
as part of Dr. Ricardo Costa’s Applied Research Fellowship, and 
Faculty of Sport Sciences and Physical Education, University of 
Coimbra.
Conflict	of	interest: The authors declare that they have no con-
flict of interest
References
1 Armstrong LE, Casa DJ, Millard-Stafford M, Moran DS, Pyne SW, Roberts 
WO. American College of Sports Medicine position stand. Exertional 
heat illness during training and competition. Med Sci Sports Exerc 
2007; 39: 556–572
2 Ashenden MJ, Lacoste A, Orhant E, Audran M, Sharpe K. Longitudinal 
variation of hemoglobin and reticulocytes in elite rowers. Hemato-
logica 2004; 89: 1403–1404
3 Banfi G, Migliorini S, Pedroni F, Galliera E, Dogliotti G, Malavazos AE, 
Corsi MM. Strenuous exercise activates growth factors and chemokines 
over-expression in human serum of top-level triathlon athletes during 
a competitive season. Clin Chem Lab Med 2008; 46: 250–252
4 Banfi G, Roi GS, Dolci A, Susta D. Behaviour of hematological parame-
ters in athletes performing marathons and ultramarathons in altitude 
(‘skyrunners’). Clin Lab Hematol 2004; 26: 373–377
5 Borges GF, Rama LM, Pedreiro S, Rosado F, Alves F, Santos AM, Paiva A, 
Teixeira AM. Hematological changes in elite kayakers during a training 
season. Applied physiology, nutrition, and metabolism. Appl Physiol 
Nutr Metab 2012; 37: 1140–1146
6 Branth S, Hambraeus L, Piehl-Aulin K, Essen-Gustavsson B, Akerfeldt T, 
Olsson R, Stridsberg M, Ronquist G. Metabolic stress-like condition can 
be induced by prolonged strenuous exercise in athletes. Ups J Med 
Sci 2009; 114: 12–25
7 Cheung SS. Interconnections between thermal perception and exercise 
capacity in the heat. Scand J Med Sci Sports 2010; 20 (Suppl 3): 53–59
8 Costa RJ, Crockford MJ, Moore JP, Walsh NP. Heat acclimation responses 
of an ultra-endurance running group preparing for hot desert-based 
competition. Eur J Sport Sci 2014; 14 (Suppl 1): S131–S141
9 Costa RJS, Teixeira A, Rama L, Swancott AJM, Hardy LD, Lee B, Camoes-
Costa V, Gill S, Waterman JP, Freeth EC, Barrett E, Hankey J, Marczak 
S, Valero-Burgos E, Scheer V, Murray A, Thake CD. Water and sodium 
intake habits and status of ultra-endurance runners during a multi-
stage ultra-marathon conducted in a hot ambient environment: an 
observational field based study. Nutr J 2013; 12
D
ow
nl
oa
de
d 
by
: D
ot
. L
ib
 In
fo
rm
at
io
n.
 C
op
yr
ig
ht
ed
 m
at
er
ia
l.
111Physiology & Biochemistry
Rama LM et al. Changes of Hematological Markers … Int J Sports Med 2016; 37: 104–111
10 Dang CV. Runner’s anemia. JAMA 2001; 286: 714–716
11 Davidson RJ, Robertson JD, Galea G, Maughan RJ. Hematological changes 
associated with marathon running. Int J Sports Med 1987; 8: 19–25
12 Dill DB, Costill DL. Calculation of percentage changes in volumes of 
blood, plasma, and red cells in dehydration. J Appl Physiol 1974; 37: 
247–248
13 El-Sayed MS, Ali N, El-Sayed Ali Z. Hemorheology in exercise and train-
ing. Sports Med 2005; 35: 649–670
14 Fallon KE, Sivyer G, Sivyer K, Dare A. Changes in hematological param-
eters and iron metabolism associated with a 1600 kilometre ultra-
marathon. Br J Sports Med 1999; 33: 27–31 discussion 32
15 Gill S, Teixeira A, Rama L, Rosado F, Hankey J, Scheer V, Hemmings K, 
Ansley-Robson P, Costa R. Circulatory Endotoxin Concentration and 
Cytokine Profile in Response to Exertional-Heat Stress During a Multi- 
Stage Ultra-Marathon Competition. Exerc Immunol Rev 2015; 21: 
114–128
16 Gleeson M. Can nutrition limit exercise-induced immunodepression? 
Nutr Rev 2006; 64: 119–131
17 Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. 
The anti-inflammatory effects of exercise: mechanisms and implica-
tions for the prevention and treatment of disease. Nat Rev Immunol 
2011; 11: 607–615
18 Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing 
repeated-measures data and its reflection in papers published in the 
Archives of General Psychiatry. Arch Gen Psychia 2004; 61: 310–317
19 Hanke AA, Staib A, Gorlinger K, Perrey M, Dirkmann D, Kienbaum P. 
Whole blood coagulation and platelet activation in the athlete: a com-
parison of marathon, triathlon and long distance cycling. Eur J Med 
Res 2010; 15: 59–65
20 Hargreaves M. Physiological limits to exercise performance in the heat. 
J Sci Med Sport 2008; 11: 66–71
21 Harriss DJ, Atkinson G. Ethical standards in sport and exercise science 
research: 2014 update. Int J Sports Med 2013; 34: 1025–1028
22 Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive sta-
tistics for studies in sports medicine and exercise science. Med Sci 
Sports Exerc 2009; 41: 3–13
23 Kakanis MW, Peake J, Brenu EW, Simmonds M, Gray B, Hooper SL, 
Marshall-Gradisnik SM. The open window of susceptibility to infec-
tion after acute exercise in healthy young male elite athletes. Exerc 
Immunol Rev 2010; 16: 119–137
24 Klapcinska B, Waskiewicz Z, Chrapusta SJ, Sadowska-Krepa E, Czuba M, 
Langfort J. Metabolic responses to a 48-h ultra-marathon run in 
middle-aged male amateur runners. Eur J Appl Physiol 2013; 113: 
2781–2793
25 Kratz A, Lewandrowski KB, Siegel AJ, Chun KY, Flood JG, Van Cott EM, 
Lee-Lewandrowski E. Effect of marathon running on hematologic and 
biochemical laboratory parameters, including cardiac markers. Am J 
Clin Pathol 2002; 118: 856–863
26 Kristensen M, Hansen T. Statistical analyses of repeated measures in 
physiological research: a tutorial. Adv Physiol Educ 2004; 28: 2–14
27 Kruger K, Lechtermann A, Fobker M, Volker K, Mooren FC. Exercise-
induced redistribution of T lymphocytes is regulated by adrenergic 
mechanisms. Brain Behav Immun 2008; 22: 324–338
28 Kruger K, Mooren FC. T cell homing and exercise. Exerc Immunol Rev 
2007; 13: 37–54
29 Levada-Pires AC, Cury-Boaventura MF, Gorjao R, Hirabara SM, Puggina 
EF, Pellegrinotti IL, Domingues Filho LA, Curi R, Pithon-Curi TC. 
Induction of lymphocyte death by short- and long-duration triathlon 
competitions. Med Sci Sports Exerc 2009; 41: 1896–1901
30 Lippi G, Banfi G, Montagnana M, Salvagno GL, Schena F, Guidi GC. Acute 
variation of leucocytes counts following a half-marathon run. Int J Lab 
Hematol 2010; 32: 117–121
31 Mairbaurl H. Red blood cells in sports: effects of exercise and training 
on oxygen supply by red blood cells. Front Physiol 2013; 4: 332
32 Mars M, Govender S, Weston A, Naicker V, Chuturgoon A. High inten-
sity exercise: a cause of lymphocyte apoptosis?  Biochem Biophys Res 
Commun 1998; 249: 366–370
33 Maughan RJ, Shirreffs SM, Ozgunen KT, Kurdak SS, Ersoz G, Binnet MS, 
Dvorak J. Living, training and playing in the heat: challenges to the 
football player and strategies for coping with environmental extremes. 
Scand J Med Sci Sports 2010; 20 (Suppl 3): 117–124
34 Millet G, Millet G. Ultramarathon is an outstanding model for the study 
of adaptive responses to extreme load and stress. BMC Med 2012; 
10: 77
35 Millet G, Millet G. Ultramarathon is an outstanding model for the study 
of adaptive responses to extreme load and stress. BMC Med 2012; 10
36 Mooren FC, Lechtermann A, Volker K. Exercise-induced apoptosis of 
lymphocytes depends on training status. Med Sci Sports Exerc 2004; 
36: 1476–1483
37 Murray A, Costa RJ. Born to run. Studying the limits of human perfor-
mance. BMC Med 2012; 10: 76
38 Robach P, Boisson RC, Vincent L, Lundby C, Moutereau S, Gergele L, 
Michel N, Duthil E, Feasson L, Millet GY. Hemolysis induced by an 
extreme mountain ultra-marathon is not associated with a decrease 
in total red blood cell volume. Scand J Med Sci Sports 2014; 24: 18–27
39 Robinson N, Saugy M, Vernec A, Pierre-Edouard S. The athlete biologi-
cal passport: an effective tool in the fight against doping. Clin Chem 
2011; 57: 830–832
40 Santos VC, Levada-Pires AC, Alves SR, Pithon-Curi TC, Curi R, Cury-
Boaventura MF. Changes in lymphocyte and neutrophil function 
induced by a marathon race. Cell Biochem Funct 2013; 31: 237–243
41 Scheer BV, Murray A. Al Andalus Ultra Trail: an observation of medical 
interventions during a 219-km, 5-day ultramarathon stage race. Clin 
J Sport Med 2011; 21: 444–446
42 Shin YO, Lee JB. Leukocyte chemotactic cytokine and leukocyte sub-
set responses during ultra-marathon running. Cytokine 2013; 61: 
364–369
43 Singer JD, Willett JB. Applied longitudinal data analysis: modeling 
change and event occurrence. Oxford; New York: Oxford University 
Press; 2003
44 Sottas PE, Robinson N, Rabin O, Saugy M. The athlete biological pass-
port. Clin Chem 2011; 57: 969–976
45 Teixeira AM, Rama L, Carvalho HM, Borges G, Carvalheiro T, Gleeson M, 
Alves F, Trindade H, Paiva A. Changes in naive and memory T-cells in 
elite swimmers during a winter training season. Brain Behav Immun 
2014  doi:10.1016/j.bbi.2014.01.002
46 Vernec AR. The Athlete Biological Passport: an integral element of 
innovative strategies in antidoping. Br J Sports Med 2014; 48: 817–819
47 Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, 
Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff 
H, Abbasi A, Simon P. Position statement. Part one: Immune function 
and exercise. Exerc Immunol Rev 2011; 17: 6–63
48 Wendt D, van Loon LJ, Lichtenbelt WD. Thermoregulation during exer-
cise in the heat: strategies for maintaining health and performance. 
Sports Med 2007; 37: 669–682
49 Wu HJ, Chen KT, Shee BW, Chang HC, Huang YJ, Yang RS. Effects of 24 h 
ultra-marathon on biochemical and hematological parameters. World 
J Gastroenterol 2004; 10: 2711–2714
50 Yazici M, Kaya A, Kaya Y, Albayrak S, Cinemre H, Ozhan H. Lifestyle 
modification decreases the mean platelet volume in prehypertensive 
patients. Platelets 2009; 20: 58–63
51 Yusof A, Leithauser RM, Roth HJ, Finkernagel H, Wilson MT, Beneke R. 
Exercise-induced hemolysis is caused by protein modification and 
most evident during the early phase of an ultraendurance race. J Appl 
Physiol 2007; 102: 582–586
D
ow
nl
oa
de
d 
by
: D
ot
. L
ib
 In
fo
rm
at
io
n.
 C
op
yr
ig
ht
ed
 m
at
er
ia
l.
